# OnCo record immunoact (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/immunoact/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "immunoact" ;
  schema:name "ImmunoACT"@en ;
  schema:description "The IIT Bombay spin-off that won India's first CAR-T approval in 2023 with NexCAR19 and has treated more than 600 patients at a tenth of Western prices."@en ;
  schema:url <https://onco.cc/companies/immunoact/>, <https://immunoact.com> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://immunoact.com>, <https://doi.org/10.1016/S2352-3026(24)00377-6> ;
  schema:addressCountry "IN" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/all-leukemia/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/>, <https://onco.cc/technologies/point-of-care-cell-manufacturing/> ;
  onco:targets <https://onco.cc/targets/cd19/> ;
  onco:drugs <https://onco.cc/drugs/talicabtagene-autoleucel/> ;
  onco:companies <https://onco.cc/companies/cipla/> ;
  onco:institutions <https://onco.cc/institutions/iit-bombay/>, <https://onco.cc/institutions/tata-memorial/>, <https://onco.cc/institutions/actrec/> ;
  onco:people <https://onco.cc/people/purwar-rahul/>, <https://onco.cc/people/jain-hasmukh/>, <https://onco.cc/people/narula-gaurav/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-manufacturing-cell-therapy/>, <https://onco.cc/bottlenecks/b-global-access/>, <https://onco.cc/bottlenecks/b-drug-pricing/> .